Authors: | Montorsi, F.; Adaikan, G.; Becher, E.; Giuliano, F.; Khoury, S.; Lue, T. F.; Sharlip, I.; Althof, S. E.; Andersson, K. E.; Brock, G.; Broderick, G.; Burnett, A.; Buvat, J.; Dean, J.; Donatucci, C.; Eardley, I.; Fugl-Meyer, K. S.; Goldstein, I.; Hackett, G.; Hatzichristou, D.; Hellstrom, W.; Incrocci, L.; Jackson, G.; Kadioglu, A.; Levine, L.; Lewis, R. W.; Maggi, M.; McCabe, M.; McMahon, C. G.; Montague, D.; Montorsi, P.; Mulhall, J.; Pfaus, J.; Porst, H.; Ralph, D.; Rosen, R.; Rowland, D.; Sadeghi-Nejad, H.; Shabsigh, R.; Stief, C.; Vardi, Y.; Wallen, K.; Wasserman, M. |
Article Title: | Summary of the recommendations on sexual dysfunctions in men |
Abstract: | Introduction. Sexual health is an integral part of overall health. Sexual dysfunction can have a major impact on quality of life and psychosocial and emotional well-being. Aim. To provide evidence-based, expert-opinion consensus guidelines for clinical management of sexual dysfunction in men. Methods. An international consultation collaborating with major urologic and sexual medicine societies convened in Paris, July 2009. More than 190 multidisciplinary experts from 33 countries were assembled into 25 consultation committees. Committee members established scope and objectives for each chapter. Following an exhaustive review of available data and publications, committees developed evidence-based guidelines in each area. Main Outcome Measures. New algorithms and guidelines for assessment and treatment of sexual dysfunctions were developed based on work of previous consultations and evidence from scientific literature published from 2003 to 2009. The Oxford system of evidence-based review was systematically applied. Expert opinion was based on systematic grading of medical literature, and cultural and ethical considerations. Results. Algorithms, recommendations, and guidelines for sexual dysfunction in men are presented. These guidelines were developed in an evidence-based, patient-centered, multidisciplinary manner. It was felt that all sexual dysfunctions should be evaluated and managed following a uniform strategy, thus the International Consultation of Sexual Medicine (ICSM-5) developed a stepwise diagnostic and treatment algorithm for sexual dysfunction. The main goal of ICSM-5 is to unmask the underlying etiology and/or indicate appropriate treatment options according to men's and women's individual needs (patient-centered medicine) using the best available data from population-based research (evidence-based medicine). Specific evaluation, treatment guidelines, and algorithms were developed for every sexual dysfunction in men, including erectile dysfunction; disorders of libido, orgasm, and ejaculation; Peyronie's disease; and priapism. Conclusions. Sexual dysfunction in men represents a group of common medical conditions that need to be managed from a multidisciplinary perspective. © 2010 International Society for Sexual Medicine. |
Keywords: | unclassified drug; anamnesis; hypertension; evidence-based medicine; disease association; clinical assessment; libido disorder; risk factors; evidence based practice; bradycardia; practice guideline; time factors; prostate cancer; prostatic neoplasms; drug induced headache; heart palpitation; thorax pain; device; practice guidelines as topic; papaverine; radical prostatectomy; medical literature; drug bioavailability; maximum plasma concentration; time to maximum plasma concentration; physical examination; heart arrhythmia; behavior therapy; erectile dysfunction; guidelines; medical ethics; coronary artery disease; testosterone; citalopram; fluoxetine; paroxetine; sertraline; phosphodiesterase v inhibitor; prostaglandin e1; sildenafil; tadalafil; vardenafil; sexual intercourse; androgen deficiency; male genital system surgery; tachycardia; cultural factor; psychotherapy; sexual behavior; social psychology; impotence, vasculogenic; device therapy; peyronie's disease; peyronie disease; penile induration; phentolamine; classification algorithm; ejaculation; amfebutamone; sexually transmitted disease; expert testimony; delayed ejaculation; premature ejaculation; priapism; adrenalin; adrenergic receptor stimulating agent; amantadine; anesthetic agent; avanafil; buspirone; clomipramine; cyproheptadine; dapoxetine; ephedrine; etilefrine; lodenafil; mirodenafil; slx 2101; udenafil; vasoactive intestinal polypeptide; yohimbine; anejaculation; anorgasmia; ejaculation disorder; male sexual dysfunction; orgasm disorder; penis injury; reflex bradycardia; topical anesthesia; vacuum constriction device |
Journal Title: | Journal of Sexual Medicine |
Volume: | 7 |
Issue: | 11 |
ISSN: | 1743-6095 |
Publisher: | Elsevier Inc. |
Date Published: | 2010-11-01 |
Start Page: | 3572 |
End Page: | 3588 |
Language: | English |
DOI: | 10.1111/j.1743-6109.2010.02062.x |
PUBMED: | 21040491 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "Source: Scopus" |